CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma.
| Image |  |
|---|---|
| Description | scientific article published on 31 March 2016 |
| Author/s |
author: Mu-Sheng Zeng Yi-Ji Liao Xin-Yuan Guan |
| Publication date | March 31, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |